JabsD.A., RosenbaumJ.T., FosterC.S., et al.Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am. J. Ophthalmol. 130:492–513, 2000.
2.
BuckleyL., GuyattG., FinkH.A., et al.American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol. 69:1521–1537, 2017.
3.
KanisJ.A., JohnellO., OdenA., JohanssonH., and McCloskeyE.FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int. 19:385–397, 2008.
4.
SirisE.S., BaimS., and NattivA.Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. Postgrad. Med. 122:82–90, 2010.
